Literature DB >> 8124213

Frequency of RAS and p53 mutations in acute promyelocytic leukemias.

L Longo1, D Trecca, A Biondi, F Lo Coco, F Grignani, A T Maiolo, P G Pelicci, A Neri.   

Abstract

The frequency of RAS and p53 mutations was investigated in 30 acute promyelocytic leukemias by single strand conformation polymorphism analysis and direct sequencing of genomic DNA. Only two cases bore N-RAS codon 12 mutations and none had p53 mutations responsible for aminoacid substitutions. It would, therefore, seem that neither RAS nor p53 are involved in acute promyelocytic leukemogenesis.

Entities:  

Mesh:

Year:  1993        PMID: 8124213     DOI: 10.3109/10428199309067933

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  7 in total

1.  Impairment of p53 acetylation, stability and function by an oncogenic transcription factor.

Authors:  Alessandra Insinga; Silvia Monestiroli; Simona Ronzoni; Roberta Carbone; Mark Pearson; Giancarlo Pruneri; Giuseppe Viale; Ettore Appella; PierGiuseppe Pelicci; Saverio Minucci
Journal:  EMBO J       Date:  2004-02-19       Impact factor: 11.598

2.  PML-RAR{alpha} and Dnmt3a1 cooperate in vivo to promote acute promyelocytic leukemia.

Authors:  Deepa Subramanyam; Cassandra D Belair; Keegan Q Barry-Holson; Haijiang Lin; Scott C Kogan; Emmanuelle Passegué; Robert Blelloch
Journal:  Cancer Res       Date:  2010-09-21       Impact factor: 12.701

3.  High ΔNp73/TAp73 ratio is associated with poor prognosis in acute promyelocytic leukemia.

Authors:  Antonio R Lucena-Araujo; Haesook T Kim; Carolina Thomé; Rafael H Jacomo; Raul A Melo; Rosane Bittencourt; Ricardo Pasquini; Katia Pagnano; Ana Beatriz F Glória; Maria de Lourdes Chauffaille; Melina Athayde; Carlos S Chiattone; Ingrid Mito; Rodrigo Bendlin; Carmino Souza; Cristina Bortolheiro; Juan L Coelho-Silva; Stanley L Schrier; Martin S Tallman; David Grimwade; Arnold Ganser; Nancy Berliner; Raul C Ribeiro; Francesco Lo-Coco; Bob Löwenberg; Miguel A Sanz; Eduardo M Rego
Journal:  Blood       Date:  2015-10-01       Impact factor: 22.113

4.  Oncogenic K-ras cooperates with PML-RAR alpha to induce an acute promyelocytic leukemia-like disease.

Authors:  Iris T Chan; Jeffery L Kutok; Ifor R Williams; Sarah Cohen; Sandra Moore; Hirokazu Shigematsu; Timothy J Ley; Koichi Akashi; Michelle M Le Beau; D Gary Gilliland
Journal:  Blood       Date:  2006-05-04       Impact factor: 22.113

5.  PML, a growth suppressor disrupted in acute promyelocytic leukemia.

Authors:  Z M Mu; K V Chin; J H Liu; G Lozano; K S Chang
Journal:  Mol Cell Biol       Date:  1994-10       Impact factor: 4.272

6.  Gene and protein analysis reveals that p53 pathway is functionally inactivated in cytogenetically normal Acute Myeloid Leukemia and Acute Promyelocytic Leukemia.

Authors:  Julia Abramowitz; Tzahi Neuman; Riki Perlman; Dina Ben-Yehuda
Journal:  BMC Med Genomics       Date:  2017-03-24       Impact factor: 3.063

7.  PML suppresses oncogenic transformation of NIH/3T3 cells by activated neu.

Authors:  J H Liu; Z M Mu; K S Chang
Journal:  J Exp Med       Date:  1995-06-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.